TLR9 agonist therapy as part of an HIV-1 curative strategy.
2019.10.29 | Health Kommunikation
Date | Fri 15 Nov |
Time | 15:30 — 17:30 |
Location | Auditorium B, G206-142, Palle Juul-Jensens Boulevard, Aarhus University Hospital (Entrance G6) |
Friday the 15th of November at 15.30 Line Khalidan Vibholm defends her PhD-dissertation entitled: “TLR9 agonist therapy as part of an HIV-1 curative strategy.”
The defence is public and takes place in Auditorium B, G206-142, Palle Juul-Jensens Boulevard, Aarhus University Hospital (Entrance G6).
PhD student Line Khalidan Vibholm
Mail: line.vibholm@clin.au.dk
Tel.: (+45) 2714 6486